Canada (English) 
Denmark 
Finland 
France 
Germany 
Ireland 
Italy 
Japan 
Norway 
Spain 
Sweden 
United Kingdom 
Global 
Adifferentkind ofbiotechcompany
Helping restore a sense of freedom for patients with hereditary angioedema (HAE) and other rare diseases.
We are BioCryst. A different kind of biotech company. A global company with over three decades of experience in drug discovery, development, and commercialization, guided by our passion for not settling for “ordinary” in our quest to develop novel medicines. We listen. We understand. We know that little things can make a big difference to patients.
Our commitment to delivering extraordinary first-in-class or best-in-class oral small-molecule and protein therapeutics is what sets BioCryst apart—and what we strive to achieve. Our transparent and supportive culture transforms employees into owners, converts challenges into resilience, and empowers people to achieve beyond what they think is possible. Let’s connect >>
A global company with a community promise
At BioCryst, advancing novel therapeutics for patients is our purpose. With our global presence, the work we do helps patients take part in the everyday activities they enjoy, wherever they live. We focus on breaking new ground by blending pioneering technology and science with a more people-focused approach. We deliver medicines that have the potential to not just move the needle, but move mountains, for patients.
Patientswe serve
Our commitment to improving the lives of patients starts with listening to and understanding the needs of patients and their loved ones. It’s about building trust and working collaboratively with advocacy organizations. It’s about getting the right treatments into the hands of patients who need them most. This is the reason we’re here.
Ourmedicines
Our focus is on breaking new ground in HAE and other rare diseases. We use a novel, structure-guided approach, blending traditional biology and medicinal chemistry with an array of advanced technologies to deliver first-in-class or best-in-class oral small-molecule and protein therapeutics to patients.
AboutUs
Founded in 1986 out of the labs of the University of Alabama at Birmingham, BioCryst is one of the oldest independent global biotechnology companies in operation. We have been guided by our commitment to never settle for ordinary in our quest to deliver novel medicines, and we continue to grow our presence around the globe to make “extraordinary” a reality for as many people as possible.